Entrada Therapeutics, Inc. (TRDA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $71.25M | -27.0% |
| 2024 | $97.64M | -57.0% |
| 2023 | $226.83M | +474.2% |
| 2022 | $39.50M | +455.2% |
| 2021 | $7.12M | +111.8% |
| 2020 | $3.36M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $71.25M | -27.0% |
| 2024 | $97.64M | -57.0% |
| 2023 | $226.83M | +474.2% |
| 2022 | $39.50M | +455.2% |
| 2021 | $7.12M | +111.8% |
| 2020 | $3.36M | — |